Sunday, 27 May 2012
Article and comments 
FDA revises Sanofi Multaq label on heart risks
19.12.2011 22:21   1 views   0 comments


(Reuters) - U.S. regulators on Monday revised the label for Sanofi SA's heart drug Multaq to reflect a doubling of health risks, including death, for some patients with irregular heart rhythms. In the updated label, the Food and Drug Administr...

View full article on health.yahoo.net »



Image with code
Comments:
Sponsored ads
Tag cloud

Afghanistan

 

American

 

Americans

 

Apple

 

Bank

 

Barack Obama

 

British

 

Carl

 

Child

 

Corp

 

Court

 

Dell

 

Democrats

 

Four

 

Hajj

 

Health

 

HealthDay

 

House

 

Iran

 

Jackson

 

John

 

June

 

Lord

 

Mark

 

Mark

 

Michael

 

Microsoft

 

Monday

 

New York

 

News

 

North

 

Obama

 

Open

 

Park

 

Police

 

President

 

Reuters

 

Rowe

 

Secretary

 

Senate

 

Some

 

Stand

 

States

 

These

 

Todd

 

United

 

United States

 

White House

 

Wire

 

World

 

Show all tags »

Copyright © 2008 - 2012 News Portal - business, entertainment, breaking news, latest news, politics, online news, top stories, weather  - all rights reserved